Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -612.78% is 1625% below its 5-year average of -35.51%, near the low end of its 5-year range (-612.78%–-20.46%).
As of the fiscal period ended Tuesday, June 30, 2026. 155.36% below its 12-month average of -239.96%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -612.78%.
RETURN ON EQUITY (ROE)
-612.78%
RETURN ON EQUITY (ROE) AVG TTM
-239.96%
RETURN ON EQUITY (ROE) AVG 3Y
-57.00%
RETURN ON EQUITY (ROE) AVG 5Y
-35.51%
RETURN ON EQUITY (ROE) AVG 10Y
-34.71%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-155.36%
CURRENT VS 3Y AVG
-975.12%
CURRENT VS 5Y AVG
-1625.44%
CURRENT VS 10Y AVG
-1665.36%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-38.56%
median of 560 covered companies
CURRENT VS SECTOR MEDIAN
-1489.16%
vs the sector median at left
Kura Oncology, Inc.
Market Cap
$950.77M
Return on Equity (ROE)
-612.78%
TTM Avg
-239.96%
3Y Avg
-57.00%
5Y Avg
-35.51%
Market Cap
$940.65M
Return on Equity (ROE)
N/A
TTM Avg
30.44%
3Y Avg
30.44%
5Y Avg
30.44%
Market Cap
$940.41M
Return on Equity (ROE)
-61.58%
TTM Avg
-50.64%
3Y Avg
-52.69%
5Y Avg
41.64%
Market Cap
$928.50M
Return on Equity (ROE)
-51.43%
TTM Avg
-27.77%
3Y Avg
3.43%
5Y Avg
3.43%
Market Cap
$981.41M
Return on Equity (ROE)
2.18%
TTM Avg
-5.89%
3Y Avg
-1.23%
5Y Avg
4.05%
Market Cap
$914.43M
Return on Equity (ROE)
5.94%
TTM Avg
5.38%
3Y Avg
4.71%
5Y Avg
4.13%
Market Cap
$999.73M
Return on Equity (ROE)
-15.09%
TTM Avg
46.85%
3Y Avg
62.20%
5Y Avg
62.20%
Market Cap
$900.50M
Return on Equity (ROE)
59.16%
TTM Avg
-57.78%
3Y Avg
-58.75%
5Y Avg
-57.09%
Market Cap
$1.00B
Return on Equity (ROE)
36.64%
TTM Avg
876.73%
3Y Avg
395.64%
5Y Avg
252.56%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kura Oncology, Inc. (KURA) | $950.77M | -612.78% | -239.96% | -57.00% | -35.51% |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $940.65M | N/A | 30.44% | 30.44% | 30.44% |
| MoonLake Immunotherapeutics (MLTX)vs › | $940.41M | -61.58% | -50.64% | -52.69% | 41.64% |
| CeriBell, Inc. (CBLL)vs › | $928.50M | -51.43% | -27.77% | 3.43% | 3.43% |
| Pacira BioSciences, Inc. (PCRX)vs › | $981.41M | 2.18% | -5.89% | -1.23% | 4.05% |
| HealthStream, Inc. (HSTM)vs › | $914.43M | 5.94% | 5.38% | 4.71% | 4.13% |
| Aktis Oncology, Inc. (AKTS)vs › | $999.73M | -15.09% | 46.85% | 62.20% | 62.20% |
| Arbutus Biopharma Corp (ABUS)vs › | $900.50M | 59.16% | -57.78% | -58.75% | -57.09% |
| MeiraGTx Holdings plc (MGTX)vs › | $1.00B | 36.64% | 876.73% | 395.64% | 252.56% |
| Bioventus Inc. (BVS)vs › | $892.39M | 23.86% | -5.16% | -37.28% | -22.23% |
ROE
-612.8%
ROA
-50.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -612.78% |
| 2026-03-31 | -273.05% |
| 2025-12-31 | -160.03% |
| 2025-09-30 | -89.42% |
| 2025-06-30 | -64.54% |
| 2025-03-31 | -49.91% |
| 2024-12-31 | -42.06% |
| 2024-09-30 | -46.62% |
| 2024-06-30 | -39.00% |
| 2024-03-31 | -33.28% |
| 2023-12-31 | -38.42% |
| 2023-09-30 | -33.25% |
| 2023-06-30 | -30.43% |
| 2023-03-31 | -34.78% |
| 2022-12-31 | -32.32% |
| 2022-09-30 | -32.28% |
| 2022-06-30 | -29.66% |
| 2022-03-31 | -27.76% |
| 2021-12-31 | -25.75% |
| 2021-09-30 | -23.21% |
| 2021-06-30 | -20.46% |
| 2021-03-31 | -17.25% |
| 2020-12-31 | -14.67% |
| 2020-09-30 | -26.54% |
| 2020-06-30 | -22.94% |
| 2020-03-31 | -33.67% |
| 2019-12-31 | -28.86% |
| 2019-09-30 | -26.27% |
| 2019-06-30 | -24.33% |
| 2019-03-31 | -39.97% |
| 2018-12-31 | -37.55% |
| 2018-09-30 | -31.56% |
| 2018-06-30 | -43.97% |
| 2018-03-31 | -34.06% |
| 2017-12-31 | -44.37% |
| 2017-09-30 | -35.91% |
| 2017-06-30 | -67.89% |
| 2017-03-31 | -56.66% |
| 2016-12-31 | -48.46% |
| 2016-09-30 | -41.92% |
| 2016-06-30 | -36.91% |
| 2016-03-31 | -32.57% |
| 2015-12-31 | -27.56% |
| 2015-09-30 | -42.77% |
| 2015-06-30 | -23.40% |
| 2015-03-31 | -9.32% |
